Literature DB >> 15377315

Development of a patient-based grading scale for PedMIDAS.

A D Hershey1, S W Powers, A-L B Vockell, S L LeCates, A Segers, M A Kabbouche.   

Abstract

The objective was to develop and validate a patient-based grading scale for PedMIDAS. PedMIDAS was administered to 329 children, who rated their overall disability based on the adult MIDAS grades. This patient-based rating and PedMIDAS scores were compared to develop the grading scale. Headache disability was rated little to none, 49.5%; mild, 26.7%; moderate, 15.8%; and severe, 7.9%, with PedMIDAS raw scores of 4.9 +/- 6.3, 17.8 +/- 14.9, 40.6 +/- 34.2, and 91.4 +/- 69.8. Convergence of these results yielded an empirically derived grading system: Grade I, 0-10; II, 11-30; III, 31-50 and IV, > 50. Higher grades corresponded to an increased need for prophylactic treatment. A patient-based grading scale further increases the utility of PedMIDAS in assessing migraine disability in children, so that it can be widely used in routine clinical evaluation and management.

Entities:  

Mesh:

Year:  2004        PMID: 15377315     DOI: 10.1111/j.1468-2982.2004.00757.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  39 in total

Review 1.  Pharmacologic treatment of migraine.

Authors:  Marcy E Yonker
Journal:  Curr Pain Headache Rep       Date:  2006-10

Review 2.  Chronic daily headaches in children.

Authors:  Andrew D Hershey; Marielle A Kabbouche; Scott W Powers
Journal:  Curr Pain Headache Rep       Date:  2006-10

3.  Predictors of Short-Term Prognosis While in Pediatric Headache Care: An Observational Study.

Authors:  Serena L Orr; Abigail Turner; Marielle A Kabbouche; Paul S Horn; Hope L O'Brien; Joanne Kacperski; Susan LeCates; Shannon White; Jessica Weberding; Mimi N Miller; Scott W Powers; Andrew D Hershey
Journal:  Headache       Date:  2019-01-23       Impact factor: 5.887

4.  Spatial Heterogeneity of Cortical Excitability in Migraine Revealed by Multifrequency Neuromagnetic Signals.

Authors:  Jing Xiang; Kimberly Leiken; Xinyao Degrauw; Benjamin Kay; Hisako Fujiwara; Douglas F Rose; Janelle R Allen; Joanne E Kacperski; Hope L O'Brien; Marielle A Kabbouche; Scott W Powers; Andrew D Hershey
Journal:  J Pain       Date:  2016-03-10       Impact factor: 5.820

Review 5.  Pediatric Pain Measurement, Assessment, and Evaluation.

Authors:  Renee C B Manworren; Jennifer Stinson
Journal:  Semin Pediatr Neurol       Date:  2016-10-17       Impact factor: 1.636

Review 6.  Topiramate in the prevention of pediatric migraine: literature review.

Authors:  Diana Ferraro; Girolamo Di Trapani
Journal:  J Headache Pain       Date:  2008-04-02       Impact factor: 7.277

7.  Diagnosing and managing headache in children.

Authors:  Paul Winner; Scott W Powers; Marielle A Kabbouche; Andrew D Hershey
Journal:  Curr Treat Options Neurol       Date:  2007-01       Impact factor: 3.598

8.  Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents: a randomized clinical trial.

Authors:  Scott W Powers; Susmita M Kashikar-Zuck; Janelle R Allen; Susan L LeCates; Shalonda K Slater; Marium Zafar; Marielle A Kabbouche; Hope L O'Brien; Chad E Shenk; Joseph R Rausch; Andrew D Hershey
Journal:  JAMA       Date:  2013-12-25       Impact factor: 56.272

Review 9.  Classification of pediatric headache.

Authors:  Paul Winner
Journal:  Curr Pain Headache Rep       Date:  2008-10

10.  Childhood and Adolescent Migraine Prevention (CHAMP) study: a double-blinded, placebo-controlled, comparative effectiveness study of amitriptyline, topiramate, and placebo in the prevention of childhood and adolescent migraine.

Authors:  Andrew D Hershey; Scott W Powers; Christopher S Coffey; Dixie D Eklund; Leigh Ann Chamberlin; Leslie L Korbee
Journal:  Headache       Date:  2013-04-17       Impact factor: 5.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.